Embecta Corp EMBC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
-
embecta to Participate in Investor Events
-
Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results
-
embecta Announces Quarterly Cash Dividend
-
Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company
-
embecta to Report Fiscal Third Quarter 2024 Financial Results
Trading Information
- Previous Close Price
- $13.29
- Day Range
- $13.40–13.81
- 52-Week Range
- $9.93–19.79
- Bid/Ask
- $13.51 / $14.33
- Market Cap
- $779.55 Mil
- Volume/Avg
- 267,667 / 409,683
Key Statistics
- Price/Earnings (Normalized)
- 3.83
- Price/Sales
- 0.69
- Dividend Yield (Trailing)
- 4.51%
- Dividend Yield (Forward)
- 4.51%
- Total Yield
- 4.51%
Company Profile
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,200
- Website
- https://www.embecta.com
Comparables
Valuation
|
Metric
|
EMBC
|
02291
|
300451
|
|---|---|---|---|
Price/Earnings (Normalized) | 3.83 | 25.91 | 83.75 |
Price/Book Value | — | 3.30 | 1.63 |
Price/Sales | 0.69 | 14.99 | 5.70 |
Price/Cash Flow | 7.09 | — | 24.74 |
Price/Earnings
EMBC
02291
300451
Financial Strength
|
Metric
|
EMBC
|
02291
|
300451
|
|---|---|---|---|
Quick Ratio | 1.40 | 5.23 | 2.68 |
Current Ratio | 2.11 | 5.61 | 3.00 |
Interest Coverage | 1.51 | 1,176.00 | 30.40 |
Quick Ratio
EMBC
02291
300451
Profitability
|
Metric
|
EMBC
|
02291
|
300451
|
|---|---|---|---|
Return on Assets (Normalized) | 12.30% | 10.75% | 0.71% |
Return on Equity (Normalized) | — | 11.48% | 0.88% |
Return on Invested Capital (Normalized) | 28.26% | 10.45% | 0.47% |
Return on Assets
EMBC
02291
300451
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Wlsgfpbvqf | Gcyky | $170.4 Bil | |||
| Becton Dickinson & Co
BDX
| Zwjkkpq | Hlmcfc | $68.6 Bil | |||
| Alcon Inc
ALC
| Hvkwcyr | Wmvycwh | $48.7 Bil | |||
| ResMed Inc
RMD
| Tlyqmrzjyz | Dmzvmz | $35.0 Bil | |||
| Coloplast AS ADR
CLPBY
| Mmqkdjtyl | Dyb | $29.2 Bil | |||
| West Pharmaceutical Services Inc
WST
| Mqkdmfmzvs | Kwgxz | $21.6 Bil | |||
| The Cooper Companies Inc
COO
| Lxbldsd | Qzlkvz | $21.3 Bil | |||
| Hologic Inc
HOLX
| Dgmyzzw | Zbncvm | $18.4 Bil | |||
| Baxter International Inc
BAX
| Pkkycykxs | Nflpt | $17.9 Bil | |||
| Align Technology Inc
ALGN
| Rcjblxpgz | Pcgcyq | $17.7 Bil |
United States